Affirm ® Upright Breast Biopsy Guidance System

Transition from screening to interventional procedures for optimal system versatility

This simple add-on to any Hologic 3D Mammography™ capable system enables quick 2D or 3D™ breast biopsies using the same imaging equipment as for mammography exams. Plus, the lateral arm upright biopsy accessory offers even more flexibility to access challenging lesions.

Stereotactic

Superior image quality

Superior image quality 4

Pinpoint subtle lesions and faint calcifications—including those that may only be visible with tomosynthesis with the 3D™ biopsy option.

Streamlined workflow

Efficient, fast, easy to learn and use. The system provides a simplified user interface to deliver a fast biopsy with fewer steps and a lower patient dose. 5

Versatile Solution

Transition from screening to interventional procedures to biopsy a wide spectrum of patients either seated or decubitus. Quickly and easily switch between standard and lateral needle approaches.

A large field of view for high-resolution stereotactic 2D or 3D™ images makes visualizing suspicious areas fast and simple.

Fast and easy to use 5

Intuitive user interface, fully integrated with the Selenia ® Dimensions ® and 3Dimensions™ systems, minimizes procedure steps and simplifies workflow with an average procedure time of 13 minutes.

Designed to remove the guesswork

Settings for all Hologic biopsy needle devices are pre-programmed, for quick setup and efficient operation, eliminating mental math with less chance for errors.

Access challenging lesions

Access challenging lesions with the optional lateral arm accessory. It installs quickly to present the needle parallel to the detector–especially valuable for thinly compressed breasts.

Affirm ® Lateral Arm Upright Biopsy Accessory

Confidently target challenging lesions and successfully biopsy thinly-compressed breasts. This versatile, easy-to-use device enables needle access parallel to the detector – from either the lateral left or lateral right position. Choose the optimal approach based on each patient’s anatomy and lesion location to accelerate and simplify biopsy procedures.

Flexible patient positioning

Positioning patients in constrained spaces is always the challenge. The Affirm lateral arm offers a number of options in biopsy rooms where decubitus positioning or rotating the C-arm may not be possible. Patients can often remain seated without sacrificing lesion accessibility.

Intuitive needle visualization

Experience improved 3D™ visualization of the biopsy needle in the breast with virtually no imaging artifacts as found in the standard approach. By presenting the needle parallel to the detector, it’s easier to see the needle aperture and more intuitive to make adjustments.

Tech Specs
Tech Specs
Biopsy Volume
Standard or Axillary Paddle 5 cm x 5 cm x 10 cm
Wide Access Paddle 6 cm x 7 cm x 10 cm
Compression Method Motorized and Manual Compression
Compression Range Up to 15 cm
Image Area 18 cm x 24 cm
Breast Positioning Area 24 cm x 29 cm
SID 70 cm
Weight < 7kg (< 15lb)
Breast Biopsy Guidance
Needle Guidance Cartesian Coordinate System Z-Axis has 10° tilt
Accuracy +/-1 mm
Stereotactic Angle +/-15°
C-Arm Positioning +180° to -140°(stereo start locations)
Guidance Movements X- and Y-Axes: Motorized Z-Axis: Manual
Range of Movement 75 mm (width) x 70 mm (depth) x 160 mm (height)
Home Positions Far Left, Far Right
Biopsy Field Illumination Integrated LED
Biopsy Control Module
Display Window Touchscreen Color LCD 800 pixels x 600 pixels
Lesion Coordinate Display Numeric, Cartesian
Display Mode Target Guidance, Jog Screen, Select Targets
Acquisition Workstation
Workflow Display 1.2 MP Touchscreen Color or Standard Color LCD display
Image Display 2 MP or 3 MP Medical Grade LCD DICOM Display
Biopsy Device Compatibility
Needle Length Up to 140mm
Biopsy Compression Paddles
Standard Biopsy Paddle
Compression Area 14 cm x 18 cm
Biopsy Opening 5.4 cm x 5.2 cm
Standard Biopsy Paddle
Compression Area 14 cm x 18 cm
Biopsy Opening 7.4 cm x 6.2 cm
Axillary Biopsy Paddle
Compression Area 9.4 cm x 18 cm
Biopsy Opening 5.4 cm x 5.2 cm
Environmental Conditions
Operating Temperature 20º to 30º C
Operating Relative Humidity 20% to 80%, non-condensing
Storing Temperature -10º to 40º C
Requirements
Selenia® Dimensions® system diagnostic license and dynamic tube head motion license for biopsy
Accessories
Geometry Calibration Phantom
Targeting Phantom
Quality Assurance Needle
Needle Guide Holder
Affirm Biopsy License (single gantry)
Tabletop Stand
User Manual
Service Manual
Optional Components
Lateral Arm Enables needle access parallel to the detector from either the lateral left or right position
Biopsy Device Mounting Standard adapters used on MultiCare ® Platinum and Digital StereoLoc ® II
Software Options A rm 3DTM Biopsy License (single gantry)
Additional A rm 3DTM Biopsy License (single gantry)
Additional A rm Stereotactic Biopsy License (single gantry)
Environmental Conditions
Operating Temperature 20˚ to 30˚ C
Operating Relative Humidity 20% to 80%, non-condensing
Storing Temperature -10˚ to 40˚ C

Your Complete Biopsy Solution

Choose Your Method: Stereotactic Ultrasound MRI

Affirm Upright

Affirm® Upright Breast Biopsy Guidance System

Tissue Acquisition Image Verification

Brevera

Brevera® Breast Biopsy System with CorLumina® Imaging Technology

Tissue Marking

SecurMark

SecurMark® Biopsy Site Markers

Looking for more information about the Affirm upright
breast biopsy guidance system?

© 2022 Hologic. 3D, 3D Mammography, Affirm, ATEC, Brevera, Contura, CorLumina, Celero, Dimensions, Eviva, MammoSite, SecurMark, Selenia, Sertera, Trident, TriMark, 5-Day Targeted Therapy, Viera, The Science of Sure and associated logos are trademarks and/or registered trademarks of Hologic, Inc., and/or its subsidiaries in the United States and/or other countries. See all trademarks. Tumark and associated logos are trademarks and/or registered trademarks of Somatex Medical Technologies GmbH. Hologic is an authorized distributor of Tumark Professional X, Q, Flex and Vision biopsy site markers.

References text

1 Compared to the MultiCare® Platinum System.

2 Preference survey results of 155 Eviva users – 2015.

3 Based on a survey of 165 patients post-procedure at 3 hospitals.

4 Compared to 2D.

5 Schrading S, Martine D, Dirrichs T, et al. “Digital Breast Tomosynthesis-guided Vacuum-assisted Breast biopsy: Initial Experiences and Comparison with Prone Stereotactic Vacuum-assisted Biopsy.” Radiology. 2015 274:3, 654-662 E-pub 2014 Nov 12.

6 Compared to standard approach.

7 Internal testing performed at Hologic and maintained in PLM, 2006, SecurMark, TriMark biopsy site markers.

9 Compared to Eviva device. 2017 data on file.

10 Internal testing performed at Hologic and maintained in PLM, 2007, Celero biopsy device.

11 Englander, B., 2013. An Evaluation of the Hologic® Celero® Vacuum Assisted Handheld Device for Ultrasound Guided Breast Biopsies, WP-00006 Rev.002 (09/13) US/International.

12 Kaplan, S. 2010. The Benefits of the Hologic Eviva Vacuum-Assisted Stereotactic Breast Biopsy Device, WP-00023 (4/11).

13 Data collected from 100 cases performed at various sites using the Sertera biopsy device.

14 2016 Kadence International survey of 200 healthcare professionals.

15 Based on Tumark® Data Collection Study, 3 clinicians at 3 hospitals for 71 marker placements, 2017.

16 Based on Tumark® Data Collection Study, 3 clinicians at 3 hospitals for 45 marker placements, 2017.

17 Shah C, Badiyan S, Ben Wilkinson J, Vicini F, Beitsch P, Keisch M, Arthur D, Lyden M. Treatment Efficacy with Accelerated Partial Breast Irradiation (APBI): Final Analysis of the American Society of Breast Surgeons MammoSite® Breast Brachytherapy Registry Trial. Ann Surg Oncol. 2013 Aug 22. [Epub ahead of print] PubMed PMID: 23975302.

18 King TA, Bolton JS, Kuske RR, et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for Tis1,2 breast cancer. Am J Surg. 2000; 180:299-304.

19 All clinical data used to support this 5-Day Targeted Therapy™ system claim was derived from use of the Mammosite® system.

20 Internal testing performed at Hologic and maintained in PLM 2018, Eviva biopsy device.

21 Internal testing performed at Hologic and maintained in PLM 2016, Sertera biopsy device.